NCT03258593 2026-03-17
Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
Clinical Trials
13 trialsNCT03388619 2026-02-23
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00924027 2025-09-05
A Study of Patients Receiving High-Dose Rate Brachytherapy
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02769962 2025-07-28
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT03142802 2025-02-10
Low-Dose CT - Stage I Testicular Cancer
University Health Network, Toronto
Phase NA Active not recruiting
NCT02809690 2023-09-07
18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer
University of Southern California
Phase 1 Terminated
NCT04521894 2023-06-09
The Application Value of 18F-prostate-specific Membrane Antigen PET/CT in Prostate Cancer
First Affiliated Hospital Xi'an Jiaotong University
Unknown
NCT03718260 2023-03-17
PREP
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Unknown
NCT05362539 2022-05-05
Novel Urine-Based DNA Methylation Biomarkers for Urothelial Bladder Carcinoma Detection in Patients With Hematuria
Mansoura University
Phase NA Completed
NCT01926990 2022-02-02
Perfusion CT Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma
Stanford University
Completed
NCT02611882 2020-12-22
PSMA PET
University of California, San Francisco
Phase 2 Completed
NCT02663817 2020-02-05
DMH-Based Plan Evaluation and Inverse Optimization in Radiotherapy
University of Miami
Phase NA Completed
NCT00252460 2016-03-25
CT/MRI Co-registration Prostate Cancer
University Health Network, Toronto
Completed